Axa’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.82M | Buy |
324,543
+523
| +0.2% | +$11K | 0.02% | 490 |
|
|
2025
Q1 | $5.31M | Buy |
324,020
+74,318
| +30% | +$1.22M | 0.02% | 526 |
|
|
2024
Q4 | $6.42M | Buy |
249,702
+41,722
| +20% | +$1.07M | 0.02% | 478 |
|
|
2024
Q3 | $6.59M | Sell |
207,980
-35,504
| -15% | -$1.12M | 0.02% | 475 |
|
|
2024
Q2 | $8.55M | Buy |
243,484
+136
| +0.1% | +$4.78K | 0.03% | 412 |
|
|
2024
Q1 | $10.7M | Buy |
243,348
+68
| +0% | +$2.98K | 0.03% | 395 |
|
|
2023
Q4 | $8.66M | Sell |
243,280
-100,475
| -29% | -$3.57M | 0.03% | 425 |
|
|
2023
Q3 | $9.27M | Sell |
343,755
-1,206
| -0.3% | -$32.5K | 0.03% | 405 |
|
|
2023
Q2 | $8.11M | Buy |
344,961
+4,745
| +1% | +$112K | 0.03% | 451 |
|
|
2023
Q1 | $4.67M | Sell |
340,216
-753
| -0.2% | -$10.3K | 0.02% | 587 |
|
|
2022
Q4 | $6.2M | Sell |
340,969
-88,149
| -21% | -$1.6M | 0.02% | 535 |
|
|
2022
Q3 | $6.4M | Buy |
429,118
+1,870
| +0.4% | +$27.9K | 0.03% | 529 |
|
|
2022
Q2 | $5.9M | Buy |
427,248
+145,144
| +51% | +$2M | 0.02% | 539 |
|
|
2022
Q1 | $3.16M | Buy |
282,104
+2
| +0% | +$22 | 0.01% | 758 |
|
|
2021
Q4 | $6.67M | Buy |
282,102
+3,369
| +1% | +$79.6K | 0.02% | 593 |
|
|
2021
Q3 | $7.11M | Buy |
278,733
+38,626
| +16% | +$985K | 0.02% | 588 |
|
|
2021
Q2 | $5.04M | Buy |
+240,107
| New | +$5.04M | 0.01% | 708 |
|